Sept 2023 - Two additional commercial manufacturing facilities, XBCM2 and XDP2, commenced operation in Wuxi to expand the manufacturing capacity and further enable our clients at both clinical and commercial stages
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- Investor RelationsAbout Us
- News & ResourcesAbout Us
About Us
Our Company
Your Single Source
for Bioconjugation Discovery, Development and cGMP Manufacturing
WuXi XDC (stock code：2268.HK), a leading Contract Research, Development and Manufacturing Organization (CRDMO) focused on the global ADC and broader bioconjugate market, is a pioneering
CRDMO offering integrated, end-to-end services. Services are provided from proximately located, state-of-the-art laboratories and manufacturing facilities,
allowing for a significant reduction in development timelines and costs. Our over 1000 skilled employees work across a global network to deliver expert-driven,
high-quality and right-first-time project execution for our customers. By offering a single-source, open-access platform with the most comprehensive
capabilities and technologies, WuXi XDC enables our biopharmaceutical partners to speed the development of innovative therapies for the benefit of patients
worldwide.
>
300
Clients worldwide
>
100
Ongoing, integrated CMC development programs*
>
20
Ongoing late-stage, integrated (Phase II / III) programs*
>
50
Successful INDs filed by our clients, enabled through WuXi XDC services
*Integrated programs comprise product development and manufacturing programs contracted to us by our clients that utilize multiple WuXi XDC development capabilities / technologies or services (e.g., cell line development, process development, analytical development, formulation and drug product development etc.) and GMP manufacturing (drug substance, drug product or both)
Vision
& Mission
Our Vision
“Linking innovation to health” by offering an open-access platform with the most comprehensive capabilities and technologies in the global ADC (antibody drug conjugate) and XDC (other novel bioconjugate) industry.
Our Mission
To continuously enhance our platform, propel and transform the development of the bioconjugate industry, enable global biopharmaceutical partners and benefit patients worldwide.
PROUD Culture
Our PROUD (Passion, Reward, Ownership, Unity, Determination) values and spirit are the driving force behind our actions and activities at WuXi XDC. Come join us to
embrace new opportunities and challenges and to help us achieve our vision!
-
P: Passion
Customer focus
Positive attitude and energy
Continuous learning -
R: Reward
Tackling tough tasks
Embracing change
Giving back to society -
O: Ownership
Accountability
Excellence and efficiency
Honesty and Ethics -
U: Unity
Diversity and inclusion
Respect and communication
Teamwork -
D: Determination
Strong execution
GROWTH mindset
Calculated risks
History
Corporate Development Footprint
Business Ethics
As a leading global open-access biologics technology platform, WuXi XDC is committed to the highest standards of ethics and integrity. We strive to deal honestly, ethically and fairly with our customers, suppliers, employees, competitors, and the communities we serve worldwide. WuXi XDC does not engage in false, misleading, deceptive or fraudulent statements for our products and services. We are dedicated to conducting business only with individuals and organizations who share our commitment to the highest ethical standards and operate in a socially and environmentally responsible manner.
In line with that commitment, the Company expects and encourages its employees, customers, suppliers and other stakeholders who have concerns about any suspected misconduct or malpractice within the Company to come forward and voice those concerns through the whistleblowing channel.
Compliance reporting: IA_biologics@wuxibiologics.com, Compliance_Biologics@wuxibiologics.com
WuXi XDC, as a subsidiary of WuXi Biologics, adheres to all business ethics, code of conduct and IP policies as established by WuXi Biologics.
Preservation of
your IP is our highest priority.
We have established stringent policies and procedures for IP protection and prosecution of IP
violations to ensure your success and win your trust.
Our purpose in business is to enable innovation for our global partners, who keep us at the top of their confidence. IP is our shared lifeline. We guard it at WuXi Biologics with our founding principles of integrity, world-class security, zero tolerance policies, and relentless pursuit of justice against any criminal act. This is our highest priority, and we must hold ourselves accountable. We are determined to earn the trust of our partners by committing to success together.
Intellectual Property Protection is the foundation of trust between WuXi XDC and our global
customers. To that end, we have established the most stringent policies in China and in U.S. for the protection of intellectual property and for avoidance of IP
violations which is aligned to the industry-leading rigorous IP protection policies of WuXi Biologics. Our purpose in business is to enable innovation for our
global partners, who keep us at the top of their confidence. We guard IP protection with our founding principles of integrity, world-class security,
zero-tolerance policies, and relentless pursuit of justice against any criminal act.
Environmental Social Governance (ESG)
We are dedicated to implementing sustainable and eco-friendly business practices by building a comprehensive and integrated Environmental, Health and Safety (EHS) management system, sourcing ethically, reducing our environmental footprint, advocating reduced energy consumption, minimizing effluent, and acting responsibly to reduce operational impact on the environment.
On our Diversity, Equity and Inclusion initiatives, we strive to advance a diverse workforce and create an equal and inclusive corporate culture. To this end, we recruit employees based on their professional and academic achievements regardless of religion, disability, age, race, color, sex, gender identity, sexual orientation, or marital status to provide equal employment opportunity.
Along with the creation of our own compliance management system and ethical standards training programs for all employees, our “Zero tolerance” for bribery and corruption principles along with our commitment to honesty and trustworthy business conduct promote our ESG culture.
WuXi XDC, as a subsidiary of WuXi Biologics, adheres to all EHS guidelines and policies as established by WuXi Biologics. The WuXi XDC ESG report can be found here.
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?